Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yong-Gong Yang"'
Autor:
Jing Wang, Yong-Gong Yang, Min Zhou, Jing-Yan Xu, Qi-Guo Zhang, Rong-Fu Zhou, Bing Chen, Jian Ouyang
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60699 (2013)
To determine whether the use of idarubicin+cytarabine (IA) is more effective than the use of daunorubicin+cytarabine (DA) as induction chemotherapy for patients with newly diagnosed acute myeloid leukaemia.A computer-based search was performed. Rando
Externí odkaz:
https://doaj.org/article/fe858efa062c4fa5aaa397beb54abee3
Autor:
Jing, Wang, Min, Zhou, Jing-Yan, Xu, Yong-Gong, Yang, Qi-Guo, Zhang, Rong-Fu, Zhou, Bing, Chen, Jian, Ouyang, Cuiping, Li
Publikováno v:
Histology and histopathology. 31(3)
The International Prognostic Index (IPI) has been the basis for determining prognosis in patients with diffuse large B-cell lymphoma (DLBCL) for the past 20 years. The utility of the IPI must be reassessed in the era of immunochemotherapy. Seven risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a68bd2808d3f94d283f6ab6d5f26475
https://pubmed.ncbi.nlm.nih.gov/26424560
https://pubmed.ncbi.nlm.nih.gov/26424560
Autor:
Da-yu, Chang, Jian, Ouyang, Rong-fu, Zhou, Jing-yan, Xu, Bing, Chen, Yong-gong, Yang, Qi-guo, Zhang, Xiao-yan, Shao, Chao-yang, Guan, Yong, Xu
Publikováno v:
Zhonghua nei ke za zhi. 49(3)
To explore the profiles of Th1, Th2, Th17 and Regulatory T (Treg) cells in patients with chronic idiopathic thrombocytopenic purpura (ITP).Samples of peripheral blood were collected from 35 chronic ITP patients (21 in an active stage group, 5 in a no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5be42a9883d4580addcd3ff2f230f03e
https://pubmed.ncbi.nlm.nih.gov/20450652
https://pubmed.ncbi.nlm.nih.gov/20450652
Autor:
Jianyong Li, Pengjun Jiang, Xue-Mei Sun, Junhao Chen, Dong Li, Yong-gong Yang, Lei-lei Chen, Wei Xie, Yu-Jie Wu, Wei Xu
Publikováno v:
Annals of hematology. 88(1)
Assay of phosphotyrosine levels using flow cytometry has been used to identify patients with chronic myelogenous leukemia positive for the Bcr-Abl fusion gene. We hypothesized that clinical monitoring could identify treatment response through reducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9696854e53cc7a8546098076e0f2e9e7
https://pubmed.ncbi.nlm.nih.gov/18696070
https://pubmed.ncbi.nlm.nih.gov/18696070
Autor:
Jing Wang, Min Zhou, Jing-Yan Xu, Yong-Gong Yang, Qi-Guo Zhang, Rong-Fu Zhou, Bing Chen, Jian Ouyang, Wang, Jing, Zhou, Min, Xu, Jing-Yan, Yang, Yong-Gong, Zhang, Qi-Guo, Zhou, Rong-Fu, Chen, Bing, Ouyang, Jian
Publikováno v:
Medicine; 9/20/2016, Vol. 95 Issue 38, p1-5, 5p
Publikováno v:
Blood. 108:4431-4431
Currently, karyotype analysis for chromosome translocation of 9 and 22 and FISH or gene amplification-based technique for bcr-abl fusion gene have been the major strategies for the diagnosis and disease status evaluation of bcr-abl positive leukemias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fcc6c769081a6f2f69eadf8d238d3ea
https://doi.org/10.1182/blood.v108.11.4431.4431
https://doi.org/10.1182/blood.v108.11.4431.4431